| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/30/2009 | WO2009033813A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009033774A3 Use of a laminin nonapeptide as a therapeutic agent |
| 07/30/2009 | WO2009033722A8 Use of a octreotide as a therapeutic agent |
| 07/30/2009 | WO2009024980A3 Pyrimidine and pyridine derivatives as posh and posh-ap inhibitors |
| 07/30/2009 | WO2009023356A3 Materials and methods for treating influenza infections |
| 07/30/2009 | WO2009016526A3 Ethers of substituted 5-hydrixy-1h-indol-3-carboxylic acids, a pharmaceutical composition and a method for the production and use thereof |
| 07/30/2009 | WO2008135796A3 Liquid vegetable tooth paste in spray or drop |
| 07/30/2009 | WO2008073957A8 Compounds and methods for modulating the silencing of a polynucleotide of interest |
| 07/30/2009 | WO2008040155A8 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 07/30/2009 | WO2008017734A8 Polymyxin derivatives and uses thereof |
| 07/30/2009 | WO2007118431A8 Use of trap protein as active ingredient for manufacturing a medicament for the treatment of staphylococcus aureus infection |
| 07/30/2009 | WO2007112753A8 Pharmaceutical composition comprising anti-mirna antisense oligonucleotides |
| 07/30/2009 | WO2007104263A8 An enhancin of hepatitis b virus vaccine and its gene |
| 07/30/2009 | US20090192308 1,5-dihydro-2h-pyrrol-2-one tricyclic derivatives having anti-infective activity |
| 07/30/2009 | US20090192293 Antibodies to non-functional p2x7 receptor |
| 07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
| 07/30/2009 | US20090192217 Method and composition for treating acne using lignan compounds |
| 07/30/2009 | US20090192195 Compounds Having CRTH2 Antagonist Activity |
| 07/30/2009 | US20090192192 Inhibitors of biofilm formation of gram-positive and gram-negative bacteria |
| 07/30/2009 | US20090192173 Anti-tubercular drugs: compositions and methods |
| 07/30/2009 | US20090192156 Phthalazinone derivatives |
| 07/30/2009 | US20090192125 Local anti-infective agent for treatment of nail fungal infections |
| 07/30/2009 | US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA) |
| 07/30/2009 | US20090192099 Prodrugs of heteroaryl compounds |
| 07/30/2009 | US20090192081 Casein derived peptides and uses thereof |
| 07/30/2009 | US20090192077 North-2'deoxy -methanocarbathymidines as antiviral agents for treatment of kaposi's sarcoma-associated herpes virus |
| 07/30/2009 | US20090191260 Aerosol and use thereof |
| 07/30/2009 | US20090191249 Sheet substrates impregnated with aromatic releasing compositions and a method of delivery of aromatic releasing compositions |
| 07/30/2009 | US20090191241 Method and compositions for immunization with the pseudomonas v antigen |
| 07/30/2009 | US20090191240 Flavivirus Vaccines |
| 07/30/2009 | US20090191237 Methods and reagents for vaccination which generate A CD8 T cell immune response |
| 07/30/2009 | US20090191234 Vaccine |
| 07/30/2009 | US20090191207 Compositions and methods for the prophylaxis or treatment of viral diseases |
| 07/30/2009 | US20090191192 Humanized anti-ccr2 antibodies and methods of use therefor |
| 07/30/2009 | US20090191189 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/30/2009 | US20090191186 Antibodies to the PcrV Antigen of Pseudomonas aeruginosa |
| 07/30/2009 | US20090191153 Oximyl macrocyclic derivatives |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/30/2009 | DE102008006416A1 Clindamycin or its salt, or a clindamycin-containing composition useful for the intracervical or endocervical treatment or prevention of bacterial vaginosis caused by anaerobic and gram positive aerobic germs |
| 07/30/2009 | CA2713105A1 Methods of treating viral infections |
| 07/30/2009 | CA2713005A1 Difluorinated tripeptides as hcv serine protease inhibitors |
| 07/30/2009 | CA2712448A1 Lactylates for the prevention and treatment of infections caused by gram-positive bacteria in animals |
| 07/30/2009 | CA2711887A1 Dihydro-1h-pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as s1p1 agonists |
| 07/30/2009 | CA2711059A1 Crystalline form of abacavir that is essentially free of solvent |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP2083012A1 1,5-dihydro-2h-pyrrol-2-one tricyclic derivatives having pharmacological activity and processes for their preparation |
| 07/29/2009 | EP2083011A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 07/29/2009 | EP2083010A1 Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof |
| 07/29/2009 | EP2083005A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 07/29/2009 | EP2082754A1 Bone defect filler, release-controlled carrier, and their production methods |
| 07/29/2009 | EP2082750A1 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 07/29/2009 | EP2082739A1 Lactylates for the prevention and treatment of infections caused by gram-positive bacteria in animals |
| 07/29/2009 | EP2082723A1 Topical anti-microbial compositions |
| 07/29/2009 | EP2082042A1 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| 07/29/2009 | EP2081926A1 Preparation and purification of mupirocin calcium |
| 07/29/2009 | EP2081598A2 Bioavailable combinations for hcv treatment |
| 07/29/2009 | EP2081588A1 Antimicrobial composition and uses thereof |
| 07/29/2009 | EP2081561A2 Methods and compositions using immunomodulatory compounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases |
| 07/29/2009 | EP1786807B1 Heterocyclic antiviral compounds |
| 07/29/2009 | EP1653955A4 Hydroxylamine substituted imidazo-containing compounds |
| 07/29/2009 | EP1455772B1 Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation |
| 07/29/2009 | EP1432441B1 Use of hmgb1 for the activation of dendritic cells |
| 07/29/2009 | EP1406608B1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 07/29/2009 | EP1401473B1 Transporters comprising spaced arginine moieties |
| 07/29/2009 | EP1395587B1 Process for the preparation of imipenem |
| 07/29/2009 | EP1389043B1 Foot and mouth disease virus vaccine |
| 07/29/2009 | EP1347805B1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/29/2009 | EP1268844B1 Modulating production of pneumococcal capsular polysaccharide |
| 07/29/2009 | EP1268443B1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 07/29/2009 | EP1261601B1 Substituted indoles for modulating nfkb activity |
| 07/29/2009 | EP1002110B2 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 07/29/2009 | EP0980434B1 Intracellular production of hepatitis c e2 truncated polypeptid |
| 07/29/2009 | CN101495186A Inhibitors of undecaprenyl pyrophosphate synthase |
| 07/29/2009 | CN101492496A A method for identification, isolation and production of antigens to a specific pathogen |
| 07/29/2009 | CN101491565A Use of Ixeris Sonchifolia Hance injection in preparing medicine for treating viral pneumonia |
| 07/29/2009 | CN101491564A Use of Ixeris Sonchifolia Hance injection in preparing anti-herpes simplex virus medicine |
| 07/29/2009 | CN101491536A Therapeutically useful synthetic oligonucleotides |
| 07/29/2009 | CN100519757C Tiacumicin production |
| 07/29/2009 | CN100519735C Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 07/29/2009 | CN100519561C Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol |
| 07/29/2009 | CN100519554C CCR5 antagonists for treating aids |
| 07/29/2009 | CN100519550C 2-oxo-indole compound having a functtion of inhibiting glycogen synthase kinase-3 |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100518739C A retroviral immunotherapy |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566721 Substituted thienol[2,3-d]pyrimidines as kinase inhibitors |
| 07/28/2009 | US7566719 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 07/28/2009 | US7566708 Substituted pyrazolo{3,4-D}pyrimidines as p38 map kinase inhibitors |
| 07/28/2009 | US7566694 Anti-pathogen treatments |
| 07/28/2009 | US7566568 Method for generating highly active human dendritic cells from peripheral blood mononuclear cells |
| 07/28/2009 | US7566550 Screening method for developing drugs against pathogenic microbes having two-component system |
| 07/28/2009 | US7566539 Anti-CCR2 antibodies and methods of use therefor |
| 07/28/2009 | US7566457 Proteins for use as vaccine to prevent dengue virus infection; immunotherapy; high serotype-specificity to be used in humans |
| 07/28/2009 | US7566450 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders |
| 07/28/2009 | CA2433591C Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same |
| 07/28/2009 | CA2372030C Infection resistant polymers, their preparation and uses |
| 07/28/2009 | CA2316447C Rantes mutants and therapeutic applications thereof |
| 07/28/2009 | CA2255804C Antitumoral method by administration of partricin derivatives |
| 07/23/2009 | WO2009091324A1 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |